HIV-1 drug resistance by ultra-deep sequencing following short Course Zidovudine, Single-Dose Nevirapine, and Single-Dose Tenofovir with Emtricitabine for prevention of mother-to-child transmission

Reshmi Samuel, Marc Noguera Julian, Roger Paredes, Raveen Parboosing, Pravi Moodley, Lavanya Singh, Anneta Naidoo, Michelle Gordon

    Research output: Contribution to journalArticleResearchpeer-review

    3 Citations (Scopus)

    Abstract

    © 2016 Wolters Kluwer Health, Inc. Antiretroviral drug resistance following pMTCT strategies remains a significant problem. With rapid advancements in next generation sequencing technologies, there is more focus on HIV drug-resistant variants of low frequency, or the so-called minority variants. In South Africa, AZT monotherapy for pMTCT, similar to World Health Organization option A, has been used since 2008. In 2010, a single dose of co-formulated TDF/FTC was included in the strategy for prevention of resistance conferred by single-dose nevirapine (sd NVP). The study was conducted in KwaZulu-Natal, South Africa, among pMTCT participants who received AZT monotherapy from 14 weeks of gestation, intrapartum AZT and sd NVP, and postpartum sd TDF/FTC. Twenty-six specimens collected at 6 weeks post-delivery were successfully sequenced using 454 ultra-deep sequencing. Non-nucleoside reverse transcriptase inhibitor (NNRTI) resistance was detected in 17 of 26 (65%) patients, 2 (7%) had Thymidine analogue mutations, and 3 (11%) had K65R. Of the 17 patients with NNRTI resistance, 11 (65%) had high-level NNRTI resistance, whereas 6 (35%) had intermediate NNRTI resistance. The levels of NNRTI resistance are much higher than would be expected, given the inclusion of antepartum AZT and postpartum TDF/FTC. This high level of NNRTI resistance could impact future NNRTI-containing treatment for a large proportion of pMTCT-exposed women. The detection of Thymidine analogue mutations highlights the need to understand the clinical impact of these on AZT-containing antiretroviral treatment in women exposed to AZT monotherapy.
    Original languageEnglish
    Pages (from-to)384-389
    JournalJournal of Acquired Immune Deficiency Syndromes
    Volume73
    Issue number4
    DOIs
    Publication statusPublished - 1 Dec 2016

    Keywords

    • HIV drug resistance
    • HIV vertical transmission
    • PMTCT

    Fingerprint Dive into the research topics of 'HIV-1 drug resistance by ultra-deep sequencing following short Course Zidovudine, Single-Dose Nevirapine, and Single-Dose Tenofovir with Emtricitabine for prevention of mother-to-child transmission'. Together they form a unique fingerprint.

    Cite this